Immunodeficient (B-NDG) mice_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen,drug development,antibody discovery

Product No	Product	Application area
110586	B-NDG mice	Immune reconstitution, CDX, transplantation, drug evaluation
110587	B-NDG nude mice	Human immune system reconstitution
110601	B-NDG B2m KO mice plus	Reduce PBMC reconstitution GVHD response and prolong experimental window
110600	B-NDG hIL15 mice	Promote human NK cell differentiation
110599	B-NDG HLA-A2.1 mice	Vaccine study
110596	B-NDG hIL6 mice	Promotes human monocyte differentiation
110590	B-NDG hTHPO mice	Without irradiation, it reduces the damage caused by irradiation to mice
110604	B-NDG hSIRPA mice	Maintain progenitor capacity
120612	B-NDG hIL7/hIL15 mice	0
110603	B-NDG hSIRPA/hCD47 mice	Evaluation of pharmacodynamic and toxicity of CD47, SIRPA targeted drugs
120609	B-NDG hCSF1/hTHPO mice	Promote differentiation of human myeloid cells without irradiation
112653	B-NDG hIL15, FcγR KO mice	0
112478	huHSC-B-NDG hIL15 mice	0
112482	huNK-B-NDG hIL15 mice	0
112449	B-NDG hB2M/HLA-A2.1 mice plus	0
112470	huHSC-B-NDG mice	0
112469	hPBMC-B-NDG mice	0
110593	B-NDG hGM-CSF mice	0
110598	B-NDG hairless mice	0
110597	B-NDG hIL7 mice	0
110595	B-NDG H2-Ab1 KO mice	0
111882	B-NDG MGMT3 mice	0
111895	B-NDG MHC I/II DKO mice plus	0
111922	B-NDG hFcRn mice	0
111856	B-NDG B2m plus/hIL15 mice	Human immune system reconstitution
110605	B-NDG Hc mice	Antibody CDC function study

バイオサイトジェンの本社は北京市にあり、江蘇省海門、アメリカのボストン、上海に子会社を保有しております。総従業員数は約1200人で、100%子会社であるEucure Biopharmaを通じて臨床開発を遂行しています。詳しくは下記のリンクをクリックして何でもお問い合わせください。